[1]
Unidad de Dermatología, Hospital Universidad del Norte, Barranquilla, Colombia. Facultad de Medicina, Universidad del Norte, Barranquilla, Colombia
[2]
Facultad de Medicina, Universidad del Norte, Barranquilla, Colombia. Unidad de Medicina General, Hospital Universidad del Norte, Barranquilla, Colombia
Primo L, Mestroni M, Allevato M, et al. Enfermedad de RosaiDorfman o histiocitosis sinusal con linfadenopatía masiva. Rev
Asoc Colomb Dermatol...
Thawerani H, Sánchez RL, Rosai J, et al. The cutaneous
manifestations of sinus histiocytosis with
massivelymphadenopathy. Arch Dermatol. 1978;114(2):191–197.
https://doi.org/10.1001/archderm.1978.01640140009003.
Conde JM, Kim AY, de Miguel R, et al. Enfermedad de RosaiDorfman cutánea: una nueva presentación clínica. Actas
Dermosifiliogr. 2018;109(7):655–657....
Xin J, Jin X, Mou Y, et al. Combined treatment for cutaneous
Rosai-Dorfman disease: a report of 2 cases. Int J Clin Exp Med.
2013;6(9):822–827.
Zhu F, Zhang JT, Xing XW, et al. Rosai-Dorfman disease: a
retrospective analysis of 13 cases. Am J Med Sci. 2013;345(3):
200–210. https://doi.org/10.1097/MAJ.0b013e3182553e2d.
Goyal G, Ravindran A, Young JR, et al. Mayo Clinic Histiocytosis
Working Group. Clinicopathological features, treatment approaches, and outcomes...
Bruce-Brand C, Schneider JW, Schubert P. Rosai-Dorfman
disease: an overview. J Clin Pathol. 2020;73:697–705. https://doi.
org/10.1136/jclinpath-2020-206733.
Bassis AV, Fairley JA, Ameln RT, et al. Cutaneous RosaiDorfman disease following pneumococcal vaccination. J Am
Acad Dermatol. 2011;65(4):890....
Grimaldi M, Perino F, Moretta G, et al. Cutaneous RosaiDorfman disease after Covid 19 vaccination treated with
thalidomide. Dermatol Ther....